Ecor1 Capital, Llc
10% Owner at Atara Biotherapeutics, Inc. (ATRA); 10% Owner at First Tracks Biotherapeutics, Inc. (TRAX)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-1.9%
vs. S&P 500-6.8%
Beat the market0%
Paper profit on buys+$66K
Total bought / sold$4.7M / $65.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 11SEC | ATRAAtara Biotherapeutics, Inc. | Buy | 507,4071,552,000 held (+49%) | $9.35 | $4.7M | +1.4% |
| Apr 22SEC | TRAXFirst Tracks Biotherapeutics, Inc. | Sell | 4,705,5753,174,519 held (−60%) | $13.81 | $65.0M | +130.6% |
- Buy
10% Owner Ecor1 Capital, Llc bought $4.7M of ATRA at $9.35 — first open-market purchase in our records; raises the stake by 49%.
- Sell
10% Owner Ecor1 Capital, Llc sold $65.0M of TRAX at $13.81 — cuts the stake by 60%.